A new collaboration between PathoQuest and Memorial Sloan Kettering Cancer Center (MSK) will test the best method to identify microorganisms responsible for infections in patients with febrile ...

Members of the team that developed MSK-ACCESS. From left to right: Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra. Photo from February 2020. One ...

NEW YORK, May 18, 2022 – New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a ...

Musculoskeletal radiology uses images of your bones, joints, and soft tissues to diagnose and treat common orthopedic problems: We are committed to providing a safe environment for your testing. We’ve ...

Objectives This study aimed to (1) develop a new measure of adherence to exercise for musculoskeletal (MSK) pain (Adherence To Exercise for Musculoskeletal Pain Tool: ATEMPT) based on previously ...

For the half of U.S. workers who suffer from a musculoskeletal (MSK) condition, surgeries have become an all-too-common solution — one to which both employees and their employers are looking for more ...

Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).

New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a comprehensive sequencing approach ...

Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: ...

When a landmark study led by Dr Deb Schrag, Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC), was published in The Lancet in 2023, it sparked worldwide attention.